During obesity and aging, a raise in the activity of aromatase enzyme converts testosterone into estrogens in men, further reducing circulating plasma levels and the ability of testosterone to exert its appropriate metabolic actions (40, 69). This evidence concerns the gene CYP19A1 and obesity due to melanocortin 4 receptor deficiency.